ArticleHealthcare (Basel, Switzerland)2024
The Financial Impact of an Employee Wellness Program Focused on Cardiovascular Disease Risk Reduction.
Article in Healthcare (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Economic and productivity outcomes of workplace health programmes incorporating blood-based laboratory screening: a systematic review.BMC health services research · 2026Pooled it
- Workplace Wellness Programs for Employees at Risk for Cardiovascular Disease: A Systematic Review.American journal of health promotion : AJHP · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEvidence for the effectiveness and cost-savings of workplace wellness programs (WWPs) is varied, likely due to the variability in program design, as not all WWPs meet the five-point criteria of a "comprehensive WWP" set by the U.S. Centers for Disease Control and Prevention. A 2019 study of changes in cardiovascular disease (CVD) risk for those enrolled in a comprehensive WWP found that nearly half of enrolled employees with moderate to high CVD risk improved their risk compared to the initial predictions. This study extends those findings by evaluating the cost-savings and return on investment (ROI) resulting from participants' CVD risk reduction from the employer's perspective.
methodCost-savings related to CVD risk were extrapolated using two studies that provided associated cost-savings for individuals participating in a WWP. Utilizing reference groups used in previous studies, we calculated cost-savings per 1% reduction in CVD risk using our population's specific CVD risk and our program-specific costs. The cost-savings were annualized per person within each risk category.
resultsAcross all risk categories, cost-savings were USD 1224 per individual or USD 4.90 ROI for every USD 1 spent. Those at risk had a higher ROI per USD 1.00 spent (USD 35.4 and USD 19.2 for males and females, respectively) than those with minimal risk. However, even those with minimal risk showed a positive ROI (USD 0.3 and USD 5.0 for males and females, respectively). CONCLUSIONS/APPLICATION TO PRACTICE: Investment in WWPs should prioritize programs that include all five elements of the standards established by the U.S Centers for Disease Control and Prevention. Well-designed and comprehensive WWPs can effectively impact employee health and lead to a positive ROI and cost-savings for employers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.